ATC

Clinical trials for ATC explained in plain language.

Never miss a new study

Get alerted when new ATC trials appear

Sign up with your email to follow new studies for ATC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New drug combo targets hard-to-treat BRAF cancers in early trial

Disease control Completed

This early-phase study tested a new drug called CFT1946, alone or combined with trametinib or cetuximab, in 89 adults with advanced solid tumors that have a BRAF V600 mutation (including melanoma, lung, colon, and thyroid cancers). The main goals were to check safety and find the…

Matched conditions: ATC

Phase: PHASE1 • Sponsor: C4 Therapeutics, Inc. • Aim: Disease control

Last updated May 01, 2026 15:59 UTC

ATC

Get alerted when new ATC trials appear

New drug combo targets hard-to-treat BRAF cancers in early trial